May 14 (Reuters) - SunLink Health Systems Inc SSY.A :
* SUNLINK HEALTH SYSTEMS, INC. ANNOUNCES FISCAL 2020 THIRD
QUARTER
RESULTS AND COVID-19 UPDATE
* Q3 LOSS PER SHARE $0.01 FROM CONTINUING OPERATIONS
* Q3 REVENUE $12.67 MILLION
* UNABLE TO DETERMINE EXTENT TO WHICH COVID-19 PANDEMIC WILL
CONTINUE TO AFFECT ITS ASSETS
* SINCE BEGINNING OF COVID-19 PANDEMIC, PHARMACY BUSINESS
HAS
EXPERIENCED NEGATIVE SALES TRENDS
* SUNLINK HEALTH SYSTEMS - SINCE BEGINNING OF COVID-19
PANDEMIC,
PHARMACY BUSINESS EXPERIENCED INCREASED COSTS AND REDUCED STAFF
* SUNLINK HEALTH - UNTIL REFERRAL SOURCES ARE FULLY-STAFFED,
BELIEVE COVID-19 WILL CONTINUE TO AFFECT DEMAND FOR DME
PRODUCTS, PHARMACY DRUGS & PRODUCTS
* REDUCTIONS IN EMPLOYEE HOURS HAVE BEEN MADE IN RESPONSE TO
LOWER
DEMAND
* DEMAND FOR INSTITUTIONAL PHARMACY SERVICES HAS BEEN LESS
AFFECTED TO DATE
* IMPACT OF COVID-19 PANDEMIC HAS NEGATIVELY AFFECTED SUPPLY
PROCESSES
* EFFECT OF COVID-19 AND PUBLIC AND GOVERNMENTAL RESPONSES
TO IT
NEGATIVELY AFFECTED Q3 RESULTS
* IN HEALTHCARE BUSINESSES, HAVE EXPERIENCED MATERIAL
REDUCTIONS
IN DEMAND DUE TO COVID-19 OUTBREAK
* SUNLINK HEALTH - IF COVID-19 PANDEMIC CONTINUES FOR
EXTENDED
PERIOD, EXPECT TO EXPERIENCE SIGNIFICANT LOSSES, ADDITIONAL
FINANCIAL ASSISTANCE WILL LIKELY BE REQUIRED
* UNABLE TO DETERMINE EXTENT TO WHICH COVID-19 PANDEMIC WILL
CONTINUE TO AFFECT CO'S ASSETS
Source text for Eikon: ID:nBw9m1z71a
Further company coverage: SSY.A
((Reuters.Briefs@thomsonreuters.com;))